JP2021061852A5 - - Google Patents

Download PDF

Info

Publication number
JP2021061852A5
JP2021061852A5 JP2021001276A JP2021001276A JP2021061852A5 JP 2021061852 A5 JP2021061852 A5 JP 2021061852A5 JP 2021001276 A JP2021001276 A JP 2021001276A JP 2021001276 A JP2021001276 A JP 2021001276A JP 2021061852 A5 JP2021061852 A5 JP 2021061852A5
Authority
JP
Japan
Prior art keywords
protein
library
candidate protein
binding site
candidate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021001276A
Other languages
English (en)
Japanese (ja)
Other versions
JP7109605B2 (ja
JP2021061852A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021061852A publication Critical patent/JP2021061852A/ja
Publication of JP2021061852A5 publication Critical patent/JP2021061852A5/ja
Application granted granted Critical
Publication of JP7109605B2 publication Critical patent/JP7109605B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021001276A 2015-05-21 2021-01-07 タンパク質の特徴を改善する方法 Active JP7109605B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562165173P 2015-05-21 2015-05-21
US62/165,173 2015-05-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017556995A Division JP6867302B2 (ja) 2015-05-21 2016-05-16 タンパク質の特徴を改善する方法

Publications (3)

Publication Number Publication Date
JP2021061852A JP2021061852A (ja) 2021-04-22
JP2021061852A5 true JP2021061852A5 (cg-RX-API-DMAC7.html) 2021-07-29
JP7109605B2 JP7109605B2 (ja) 2022-07-29

Family

ID=57320465

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017556995A Active JP6867302B2 (ja) 2015-05-21 2016-05-16 タンパク質の特徴を改善する方法
JP2021001276A Active JP7109605B2 (ja) 2015-05-21 2021-01-07 タンパク質の特徴を改善する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017556995A Active JP6867302B2 (ja) 2015-05-21 2016-05-16 タンパク質の特徴を改善する方法

Country Status (5)

Country Link
US (2) US10526597B2 (cg-RX-API-DMAC7.html)
EP (1) EP3297661B1 (cg-RX-API-DMAC7.html)
JP (2) JP6867302B2 (cg-RX-API-DMAC7.html)
ES (1) ES2881683T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016187101A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3297672B1 (en) 2015-05-21 2021-09-01 Harpoon Therapeutics, Inc. Trispecific binding proteins and methods of use
EP3297661B1 (en) 2015-05-21 2021-06-30 Full Spectrum Genetics, Inc. Method of improving characteristics of proteins
US11623958B2 (en) 2016-05-20 2023-04-11 Harpoon Therapeutics, Inc. Single chain variable fragment CD3 binding proteins
KR102530742B1 (ko) 2016-05-20 2023-05-09 하푼 테라퓨틱스, 인크. 단일 도메인 혈청 알부민 결합 단백질
JP7215997B2 (ja) 2016-11-23 2023-01-31 ハープーン セラピューティクス,インク. 前立腺特異的膜抗原(psma)を標的とする三重特異性タンパク質と使用方法
KR102275008B1 (ko) 2016-11-23 2021-07-13 하푼 테라퓨틱스, 인크. 전립선 특이 막 항원 결합 단백질
WO2018160754A2 (en) 2017-02-28 2018-09-07 Harpoon Therapeutics, Inc. Inducible monovalent antigen binding protein
SG10202107880XA (en) 2017-05-12 2021-09-29 Harpoon Therapeutics Inc Mesothelin binding proteins
US10730954B2 (en) 2017-05-12 2020-08-04 Harpoon Therapeutics, Inc. MSLN targeting trispecific proteins and methods of use
IL315737A (en) 2017-10-13 2024-11-01 Harpoon Therapeutics Inc B-cell maturation antigen-binding proteins
CA3078969A1 (en) 2017-10-13 2019-04-18 Harpoon Therapeutics, Inc. Trispecific proteins and methods of use
MX2020012217A (es) 2018-05-14 2021-03-02 Harpoon Therapeutics Inc Porción de unión para activación condicional de moléculas de inmunoglobulina.
US12195544B2 (en) 2018-09-21 2025-01-14 Harpoon Therapeutics, Inc. EGFR binding proteins and methods of use
CN119306844A (zh) 2018-09-25 2025-01-14 哈普恩治疗公司 Dll3结合蛋白及使用方法
WO2020232303A1 (en) 2019-05-14 2020-11-19 Harpoon Therapeutics, Inc. EpCAM BINDING PROTEINS AND METHODS OF USE
BR112022016550A2 (pt) 2020-02-21 2022-11-16 Harpoon Therapeutics Inc Proteínas de ligação a flt3 e métodos de uso

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2079802C (en) 1990-04-05 2001-09-18 Roberto Crea Walk-through mutagenesis
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
AU1456101A (en) 1999-11-03 2001-05-14 Maxygen, Inc. Antibody diversity generation
DE60224720D1 (en) * 2001-11-22 2008-03-06 Univ Keio Re
EP1660186B1 (en) 2003-08-18 2013-12-25 MedImmune, LLC Humanization of antibodies
US20060228350A1 (en) 2003-08-18 2006-10-12 Medimmune, Inc. Framework-shuffling of antibodies
US20060160178A1 (en) * 2003-11-17 2006-07-20 Jonathan Rothberg Methods of generating antibody diversity in vitro
ATE528396T1 (de) 2004-07-06 2011-10-15 Bioren Inc Look-through-mutagenese zur entwicklung veränderter polypeptide mit verbesserten eigenschaften
US8633139B2 (en) 2007-12-21 2014-01-21 Abbvie Biotherapeutics Inc. Methods of screening complex protein libraries to identify altered properties
US20120077691A1 (en) * 2010-09-24 2012-03-29 Full Spectrum Genetics, Inc. Method of analyzing binding interactions
JP5920835B2 (ja) * 2010-12-01 2016-05-18 田辺三菱製薬株式会社 無細胞翻訳系でFabを提示しうるポリヌクレオチド構築物ならびにそれを用いたFabの製造方法およびスクリーニング方法
US20120258866A1 (en) 2011-04-05 2012-10-11 Full Spectrum Genetics, Inc. Multi-dimensional selection of protein mutants using high throughput sequence analysis
US10947305B2 (en) 2015-03-20 2021-03-16 Full Spectrum Genetics, Inc. Anti-TNFα binding compounds and uses thereof
EP3297661B1 (en) 2015-05-21 2021-06-30 Full Spectrum Genetics, Inc. Method of improving characteristics of proteins

Similar Documents

Publication Publication Date Title
KR20230017781A (ko) 코로나바이러스에 대한 변이체 핵산 라이브러리
JP2025037968A (ja) 単一ドメイン抗体のバリアント核酸ライブラリー
KR20210144698A (ko) 항체 최적화를 위한 변이 핵산 라이브러리
ES2881683T3 (es) Procedimiento para mejorar las características de las proteínas
Spiliotopoulos et al. Sensitive recovery of recombinant antibody clones after their in silico identification within NGS datasets
RU2714156C2 (ru) С5-связующие полипептиды
WO2023091614A2 (en) Dickkopf-1 variant antibodies and methods of use
Lind et al. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains
CN108149325A (zh) Dna编码动态分子库的合成与筛选方法
EP1003853B1 (en) Methods for protein screening
Nithun et al. Deciphering the role of the Ser‐phosphorylation pattern on the DNA‐binding activity of max transcription factor using chemical protein synthesis
Rohden et al. Through the looking glass: milestones on the road towards mirroring life
RU2014102617A (ru) Выявление аффинно-зрелых человеческих антител
Shahsavarian et al. Exploitation of rolling circle amplification for the construction of large phage-display antibody libraries
KR101508219B1 (ko) 포도상구균의 테이코산에 대한 rna 앱타머
CN112941634B (zh) 通过dna编码化合物库筛选同时结合多个生物靶标的化合物的方法
Staudt et al. Development of an antigen microarray for high throughput monoclonal antibody selection
AU2023384167A1 (en) Chromatin profiling compositions and methods
CN102719443A (zh) 一种羧基末端特异的抗人淀粉样蛋白单克隆抗体基因和其编码多肽及应用
Kitamura et al. Development of systemic in vitro evolution and its application to generation of peptide-aptamer-based inhibitors of cathepsin E
JP2020534796A (ja) エピトープ翻訳後修飾状態に特異的な抗体の開発方法及び開発のための組成物
McCarthy et al. Altering the fine specificity of an anti-Legionella single chain antibody by a single amino acid insertion
JP2008534016A (ja) プールされたdnaを用いる遺伝子合成
He et al. Production of protein arrays by cell-free systems
Cotten et al. mRNA display-based selections using synthetic peptide and natural protein libraries